Results from a recent study published in Nature show that novel vaccine combinations can provide partial protection against infection by Simian Immunodeficiency Virus (SIV) in rhesus monkeys.
Results from a recent study published in Nature show that novel vaccine combinations can provide partial protection against infection by Simian Immunodeficiency Virus (SIV) in rhesus monkeys.
In its report concerning federally-sponsored research involving human volunteers, the Commission concluded that current rules and regulations provide adequate safeguards to mitigate risk.